Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Does creatine supplementation enhance the effects of physical training during pulmonary rehabilitation in COPD?

SarahJ. Deacon, EmmaE. Vincent, SallyJ. Singh, MichaelC. Steiner, Paul Greenhaff, MichaelD. Morgan
European Respiratory Review 2006 15: 187-189; DOI: 10.1183/09059180.00010116
SarahJ. Deacon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EmmaE. Vincent
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SallyJ. Singh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MichaelC. Steiner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Greenhaff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MichaelD. Morgan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

We conducted a randomised, placebo-controlled trial to examine whether creatine supplementation augments the benefits of pulmonary rehabilitation (PR), containing aerobic exercise and resistance training (RT).

80 subjects with COPD (GOLD stages I–IV) [mean (SD) age 68 (7.8) yrs, FEV1 44.1 (20.3) % predicted] completed 21 sessions of PR, with enhanced RT, following baseline measurements and randomisation to take creatine (Cr) or placebo (Pl) supplement. A subgroup had muscle biopsies.

Groups were well matched at baseline except for gender (M:F Cr 19:19, Pl 31:11, Chi2 p = 0.03). Mean change in functional performance & muscle strength after PR are shown. Health status (CRQ-SR) improved significantly after PR but did not differ between groups. Muscle biopsies showed evidence of creatine uptake.

This adequately powered study showed significant improvements in all outcomes following PR. Creatine supplementation did not enhance these benefits.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

THE BACKGROUND TO OUR RESEARCH

Chronic obstructive pulmonary disease (COPD) is the most common cause of disability due to lung disease. Patients are disabled by their inability to carry out many activities of daily living because of reduced exercise tolerance. This leads to social isolation, depression, and dependence and an increased burden on carers. General population ageing means that chronic disability due to COPD is expected to increase worldwide in the next three decades [1]. Improving physical performance in elderly patients is therefore an important therapeutic goal.

Exercise limitation does not correlate well with airway function and many patients will complain of leg fatigue, as well as breathlessness, as a prominent symptom that limits exercise [2–4]. Loss of muscle strength accompanies ageing and peripheral skeletal muscle dysfunction may be one of the primary determinants of disability in chronic lung disease [5]. Skeletal muscle strength and bulk are often reduced and there is evidence to suggest an impairment of oxidative metabolism [6]. Given that deconditioning is one of the principal causes of muscle dysfunction, exercise training is a logical step to improve physical performance. The role of exercise training in pulmonary rehabilitation is well established and is known to improve exercise capacity and health status in patients with chronic lung disease [7, 8]. These improvements are partly due to metabolic adaptations in the peripheral muscles. Other benefits include a reduction in usage of health services and a decrease in the number of days spent in hospital following an acute admission [9]. The cost-effectiveness of introducing pulmonary rehabilitation to standard therapy has been demonstrated [10].

Nutritional supplements have been widely used in an attempt to increase muscle mass and enhance performance. More recently, there has been growing interest in creatine supplementation in various patient groups. Creatine is a naturally occurring substance and supplementation is popular amongst athletes to augment their training and performance [11]. It is thought that creatine, in its phosphorylated form, enhances performance by increasing the phosphagen pool available for rapid resynthesis of adenosine triphosphate from adenosine diphosphate during periods of high ATP turnover. It may also have a stimulatory effect on phosphocreatine (PCr) resynthesis [12]. Creatine can increase muscle bulk and enhance high intensity exercise training in healthy subjects. Uptake is increased by exercise and supplementaion is likely to be most beneficial when combined with training. There is evidence from muscle biopsy studies that PCr levels are lower in patients with COPD than in healthy subjects [13]. This may represent a potential therapeutic target to improve exercise performance.⇓

View this table:
  • View inline
  • View popup

Our hypothesis was that creatine supplementation in association with exercise training would augment the benefits of pulmonary rehabilitation. A number of studies have previously investigated the effects of creatine supplementation and there are possible benefits in neuromuscular disease, heart failure, cystic fibrosis and the healthy elderly. Recent meta-analyses suggest that creatine does enhance performance during resistance training programmes [14, 15]. Only one study on the effects of creatine supplementation in patients with COPD during pulmonary rehabilitation has been published, concluding that creatine increases fat-free mass, peripheral muscle strength and endurance and health status, but not exercise capacity [16]. This study [16] involved only a small sample of patients and a larger, randomised controlled trial is needed in order to apply the results to the general COPD population.

MY JOB AND THE UNIT IN WHICH I WORK

The Dept of Respiratory Medicine at Glenfield Hospital is part of the University Hospitals of Leicester NHS Trust, Leicester, UK. Our rehabilitation programme is one of the largest and was also one of the first to be established in the UK. Pulmonary rehabilitation is well established for patients with COPD, but we also include patients with other disabling respiratory illnesses.

I work within a large multidisciplinary team led by Dr Mike Morgan and Prof. Sally Singh. There is a strong background of research in our department involving physiotherapists, occupational therapists, nurses and doctors. The incremental and endurance shuttle walk tests and a self-administered form of the Chronic Respiratory Disease Questionnaire were developed through projects at Glenfield Hospital [17–19]. We are able to recruit large numbers of subjects into clinical trials due to the size of our rehabilitation programme. We have now developed a strong collaboration with Prof. Paul Greenhaff in Nottingham, UK, who is involved in our current research programme on muscle metabolism in COPD. With his help we have developed a safe technique to obtain peripheral muscle samples at rest and immediately after exercise in COPD patients. Using this technique we have shown that resting PCr levels in muscle correlates with the incremental shuttle walking distance, suggesting a role for PCr in determining maximal walking performance [20]. We have also shown that exercise induces a significant decline in ATP concentrations in muscle that is abolished after exercise training [21].

MY WINNING POSTER AS PART OF MY RESEARCH

I have recently completed an MD project entitled “Enhancement of cellular adaptation to physical training in chronic obstructive pulmonary disease. A randomised placebo controlled trial of creatine supplementation”. This study was supported by a British Lung Foundation Project Grant. Patients attended a standard 7-week multidisciplinary pulmonary rehabilitation programme, consisting of three 2-h sessions per week and comprising educational talks and strength and endurance training. The programme was enhanced with individually prescribed, progressive strength training exercises, closely monitored by a research nurse. Patients were randomised to receive creatine or placebo supplements administered during the course of pulmonary rehabilitation.

THE IMPACT OF MY WORK ON CLINICAL OR RESEARCH PRACTICE

Randomised controlled clinical trials such as this are difficult because large numbers of subjects are required and they need to be adequately powered to detect clinically important differences. Our preliminary results, presented in our winning abstract, suggest that creatine is not helpful in enhancing functional performance in subjects with COPD. Of course, there may be other ergogenic aids available that need to be studied.

    • © ERSJ Ltd

    References

    1. ↵
      Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Gobal Burden of Disease Study. Lancet 1997; 349: 1498–1504.
      OpenUrlCrossRefPubMed
    2. ↵
      Levy RD, Ernst S, Levine SM, et al. Exercise performance after lung transplantation. J Heart Lung Transplant 1993; 12: 2–33.
      OpenUrl
    3. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJ. Exercise capacity and ventilatory, circulatory and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992; 146: 935–940.
      OpenUrlCrossRefPubMed
    4. ↵
      Killian KJ, Summers E, Jones NL, Campbell EJ. Dyspnea and leg effort during incremental cycle ergometry. Am Rev Respir Dis 1992; 145: 1339–1345.
      OpenUrlCrossRefPubMed
    5. ↵
      Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999; 159: S1–S40.
      OpenUrlPubMed
    6. ↵
      Gosselink R, Decramer M. Peripheral skeletal muscle and exercise performance in patients with chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 1998; 53: 419–423.
      OpenUrlPubMed
    7. ↵
      Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996; 348: 1115–1119.
      OpenUrlCrossRefPubMed
    8. ↵
      Clark CJ, Cochrane L, Mackay E. Low intensity peripheral muscle conditioning improves exercise tolerance and breathlessness in COPD. Eur Respir J 1996; 9: 2590–2596.
      OpenUrlAbstract
    9. ↵
      Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation; a randomised controlled trial. Lancet 2000; 355: 362–368.
      OpenUrlCrossRefPubMed
    10. ↵
      Griffiths TL, Phillips CJ, Davies S, Burr ML, Campbell IA. Cost effectiveness of an outpatient multidisciplinary team pulmonary rehabilitation programme. Thorax 2001; 56: 779–784.
      OpenUrlAbstract/FREE Full Text
    11. ↵
      Greenhaff PL. Creatine and its application as an ergogenic aid. Int J Sport Nutr 1995; 5: Suppl. S100–S110.
      OpenUrlPubMed
    12. ↵
      Casey A, Constantin-Teodosiu D, Howell S, Hultman E, Greenhaff PL. Creatine ingestion favourably affects performance and muscle metabolism during maximal exercise in humans. Am J Physiol 1996; 271: E31–E37.
      OpenUrlPubMed
    13. ↵
      Fiaccadori E, Del Canale S, Vitali P, Coffrini E, Ronda N, Guariglia A. Skeletal muscle energetics, acid–base equilibrium and lactate metabolism in patients with severe hypercapnia and hypoxemia. Chest 1987; 92: 883–887.
      OpenUrlCrossRefPubMed
    14. ↵
      Branch JD. Effect of creatine supplementation on body composition and performance: a meta-analysis. Int J Sport Nutr Exerc Metab 2003; 13: 198–226.
      OpenUrlPubMed
    15. ↵
      Nissen SL, Sharp RL. Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis. J Appl Physiol 2003; 94: 651–659.
      OpenUrlAbstract/FREE Full Text
    16. ↵
      Fuld JP, Kilduff LP, Neder JA, et al. Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 2005; 60: 531–537.
      OpenUrlAbstract/FREE Full Text
    17. ↵
      Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992; 47: 1019–1024.
      OpenUrlAbstract/FREE Full Text
    18. Revill SM, Morgan MD, Singh SJ, Williams J, Hardman AE. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999; 54: 213–222.
      OpenUrlAbstract/FREE Full Text
    19. ↵
      Williams JE, Singh SJ, Sewell L, Guyatt GH, Morgan MD. Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax 2001; 56: 954–959.
      OpenUrlAbstract/FREE Full Text
    20. ↵
      Steiner MC, Sewell L, Patel P, et al. A technique for sampling the quadriceps muscle during exercise in patients with COPD. Thorax 2000; 55: Suppl. 3 A50
      OpenUrl
    21. ↵
      Steiner MC, Sewell L, Patel P, et al. Endurance training improves skeletal muscle ATP turnover during exercise in COPD patients. Am J Respir Crit Care Med 2001; 163: Suppl. 5 A14
      OpenUrl
    PreviousNext
    Back to top
    View this article with LENS
    Vol 15 Issue 101 Table of Contents
    European Respiratory Review: 15 (101)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Does creatine supplementation enhance the effects of physical training during pulmonary rehabilitation in COPD?
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    Does creatine supplementation enhance the effects of physical training during pulmonary rehabilitation in COPD?
    SarahJ. Deacon, EmmaE. Vincent, SallyJ. Singh, MichaelC. Steiner, Paul Greenhaff, MichaelD. Morgan
    European Respiratory Review Dec 2006, 15 (101) 187-189; DOI: 10.1183/09059180.00010116

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Does creatine supplementation enhance the effects of physical training during pulmonary rehabilitation in COPD?
    SarahJ. Deacon, EmmaE. Vincent, SallyJ. Singh, MichaelC. Steiner, Paul Greenhaff, MichaelD. Morgan
    European Respiratory Review Dec 2006, 15 (101) 187-189; DOI: 10.1183/09059180.00010116
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • Abstract
      • THE BACKGROUND TO OUR RESEARCH
      • MY JOB AND THE UNIT IN WHICH I WORK
      • MY WINNING POSTER AS PART OF MY RESEARCH
      • THE IMPACT OF MY WORK ON CLINICAL OR RESEARCH PRACTICE
      • References
    • Figures & Data
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Smoking and impact on health
    • Nonpharmacological smoking cessation interventions in clinical practice
    • Pharmacological treatments for tobacco dependence
    Show more Original Articles

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERR

    • Journal information
    • Editorial board
    • Reviewers
    • Press
    • Permissions and reprints
    • Advertising
    • Sponsorship

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN: 0905-9180
    Online ISSN: 1600-0617

    Copyright © 2022 by the European Respiratory Society